Im probably drawing a long bow here but the CSIRO paper says.:
"The repair of cardiac tissue with cells delivered by an appropriate bioscaffold is expected to offer a superior, long-lasting treatment strategy."
The other cardiocell ..with 2 Ls in the spelling is focussed on the injection of stem cells into the damaged heart muscle of people who have heart attacks.
I wonder if some cardiocel material placed inside the damaged muscle may assist the cardiocell injection method?
So many opprtunities for AHZ to consider.
fox
GreatExposure, page-6
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
0.000(0.00%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $13.33 | $13.91 | $13.14 | $302.2K | 22.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 299 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.49 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |